Clinical Trial Update: Evaluation of 3 Different Doses of IV Busulfan [Phase 2]

View source ↗

Summary

Clinical Trial Update on a Phase 2 study evaluating three different doses of intravenous busulfan in patients with myelodysplastic syndrome and acute myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING